WHO ICTRP trial
An open label randomized crossover study on hybrid assistive limb (HAL) therapy…
JPRN-UMIN000031376 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000031376 |
|---|---|
| Public title | An open label randomized crossover study on hybrid assistive limb (HAL) therapy for Parkinson disease |
| Scientific title | An open label randomized crossover study on hybrid assistive limb (HAL) therapy for Parkinson disease - An efficacy study on hybrid assistive limb (HAL) therapy for Parkinson disease |
| Primary sponsor | Ichinomiya Nishi Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Parkinson disease |
| Interventions | In the HAL therapy group, the patients undergo walking training with HAL for 40 minutes a day, 9 times in total, and walking training without HAL for 40 minutes a day, 2 times. In the conventional rehabilitation group, the patients undergo… |
| Registration date | Feb 20, 2018 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: